-
-
-
-
-
-
L129349-100mgLumiracoxib is a novel, selective COX-2 inhibitor with IC50 and Ki of 0.14 μM and 0.06 μM, exhibits 515-fold selectivity over COX-1.A Cox-2 selective inhibitor and NSAID.
-
L129349-10mgLumiracoxib is a novel, selective COX-2 inhibitor with IC50 and Ki of 0.14 μM and 0.06 μM, exhibits 515-fold selectivity over COX-1.A Cox-2 selective inhibitor and NSAID.
-
L129349-1gLumiracoxib is a novel, selective COX-2 inhibitor with IC50 and Ki of 0.14 μM and 0.06 μM, exhibits 515-fold selectivity over COX-1.A Cox-2 selective inhibitor and NSAID.
-
L129349-250mgLumiracoxib is a novel, selective COX-2 inhibitor with IC50 and Ki of 0.14 μM and 0.06 μM, exhibits 515-fold selectivity over COX-1.A Cox-2 selective inhibitor and NSAID.
-
L129349-50mgLumiracoxib is a novel, selective COX-2 inhibitor with IC50 and Ki of 0.14 μM and 0.06 μM, exhibits 515-fold selectivity over COX-1.A Cox-2 selective inhibitor and NSAID.
-
M341438-5mgMeclofenamic Acid is an anti-inflammatory and antipyretic.
-
M650053-10mgMizacorat (AZD9567: compound 15) is a potent, oral active, non-steroidal and selective glucocorticoid receptor modulator (SGRM) , with an IC 50 of 3.8 nM. Exhibits excellent efficacy in the streptococcal cell wall (SCW) reactivation model of joint